A new study from the MD Anderson Cancer Center reveals that quitting smoking within six months of a cancer diagnosis can significantly improve...

Medicaid expansion under the Affordable Care Act (ACA) is associated with better outcomes for patients with hormone receptor (HR)-negative, human...

Using a gene signature technique to customize chemotherapy for patients with early triple negative breast cancer may be a promising strategy to...

With over 27,000 women in the Philippines diagnosed with breast cancer in 2021 alone, the need for early detection and treatment has never been more...

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can directly...

Breast cancer is one of the most common cancers affecting women worldwide. It occurs when cells in the breast grow uncontrollably, forming a tumor....

Learn how a gene signature technique personalizes chemotherapy for early triple-negative breast cancer, improving disease-free survival rates

Tissue stiffness in HER2-negative breast cancer, the most common type, can directly contribute to disease progression and metastasis, which can have...

Breast cancer can sometimes be asymptomatic, even when a lump is not present. Regular self-exams and screenings are crucial for early detection and...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...